Breaking News Instant updates and real-time market news.

MYGN

Myriad Genetics

$25.55

0.34 (1.35%)

17:01
08/08/17
08/08
17:01
08/08/17
17:01

Myriad Genetics sees FY18 adjusted EPS $1.00-$1.85, consensus $1.01

Sees FY18 revenue $750M-$777M, consensus $764.72M.

  • 08

    Aug

MYGN Myriad Genetics
$25.55

0.34 (1.35%)

06/29/17
JPMS
06/29/17
NO CHANGE
Target $16
JPMS
Underweight
JPMorgan keeps Underweight rating, $16 target on Myriad Genetics
With the shares up 30% over the past month, JPMorgan analyst Tycho Peterson maintains an Underweight rating on Myriad Genetics with a $16 price target. While the company's pipeline "intriguing," it is not enough to offset a continued decline in the core hereditary cancer business, Peterson tells investors in a research note. He believes near-term catalysts could drive the stock "meaningfully higher or lower," and highlights the FY18 guidance in the Q4 earnings report as being the most significant upcoming event.
04/05/17
04/05/17
NO CHANGE

Myriad Genetics publishes pivotal studies for myPath melanoma test
Myriad Genetics has published the third clinical validation study and second clinical utility study for its myPath Melanoma test, which completes the reimbursement dossier for the product. The company will submit the reimbursement dossier to Medicare and private insurers three months earlier than expected. myPath Melanoma is an objective genetic test that measures 23 genes to help differentiate malignant melanoma from benign lesions. The third clinical validation was published in the journal Cancer Epidemiology, Biomarkers & Prevention. The study assessed the performance of the myPath Melanoma test in an independent cohort of 182 patients with melanocytic lesions against clinically proven outcomes. The results showed that the myPath Melanoma test had an overall diagnostic accuracy of 95% to effectively differentiate melanoma from benign lesions. The second clinical utility study was designed to evaluate changes in real world patient management based upon the myPath Melanoma test result. Results showed a 71% change in patient management from pre-test recommendations and an 81% reduction in biopsy site re-excisions for patients with a benign test result.
03/28/17
DBAB
03/28/17
NO CHANGE
Target $15
DBAB
Sell
Zejula label removes upside catalyst for Myriad, says Deutsche Bank
Deutsche Bank analyst Dan Leonard says FDA approval of Tesaro's (TSRO) Zejula, with a "broad rather than biomarker-limited label," removes one potential upside catalyst for Myriad Genetics (MYGN). While some investors are surprised by the broad label, many had already discounted the possibility of a label that limited usage to biomarker positive patients, which would have benefited test-supplier Myriad, Leonard tells investors in a research note. The analyst keeps a Sell rating on Myriad with a $15 price target.
03/13/17
SPHN
03/13/17
UPGRADE
SPHN
Overweight
Myriad Genetics upgraded to Overweight from Equal Weight at Stephens

TODAY'S FREE FLY STORIES

BBD

Banco Bradesco

$9.43

-0.23 (-2.38%)

09:32
12/11/18
12/11
09:32
12/11/18
09:32
Downgrade
Banco Bradesco rating change  »

Banco Bradesco downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$169.61

1.24 (0.74%)

, GOOG

Alphabet

$1,040.02

3.5 (0.34%)

09:29
12/11/18
12/11
09:29
12/11/18
09:29
Periodicals
Apple launches mobile payments service in Germany, Reuters reports »

Apple (AAPL) launched its…

AAPL

Apple

$169.61

1.24 (0.74%)

GOOG

Alphabet

$1,040.02

3.5 (0.34%)

GOOGL

Alphabet Class A

$1,052.80

5.81 (0.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 03

    Mar

TBPH

Theravance Biopharma

$27.00

0.18 (0.67%)

09:28
12/11/18
12/11
09:28
12/11/18
09:28
Conference/Events
Theravance Biopharma to host research and development day »

Research and Development…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

ZEN

Zendesk

$58.62

0.21 (0.36%)

09:27
12/11/18
12/11
09:27
12/11/18
09:27
Conference/Events
Zendesk management to meet with William Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 13

    Dec

  • 19

    Dec

  • 20

    Dec

KAR

KAR Auction

$50.43

-0.61 (-1.20%)

09:26
12/11/18
12/11
09:26
12/11/18
09:26
Conference/Events
KAR Auction management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 13

    Dec

AXP

American Express

$105.82

-0.905 (-0.85%)

09:25
12/11/18
12/11
09:25
12/11/18
09:25
Conference/Events
American Express management to meet with William Blair »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

  • 12

    Dec

CVS

CVS Health

$73.34

-0.75 (-1.01%)

, AET

Aetna

$0.00

(0.00%)

09:25
12/11/18
12/11
09:25
12/11/18
09:25
Recommendations
CVS Health, Aetna, Amazon.com analyst commentary  »

CVS Health assumed with…

CVS

CVS Health

$73.34

-0.75 (-1.01%)

AET

Aetna

$0.00

(0.00%)

AMZN

Amazon.com

$1,640.37

11.18 (0.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

  • 20

    Dec

STNG

Scorpio Tankers

$2.05

(0.00%)

09:25
12/11/18
12/11
09:25
12/11/18
09:25
Conference/Events
Scorpio Tankers to host an analyst and investor day »

Analyst and Investor Day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

09:25
12/11/18
12/11
09:25
12/11/18
09:25
Conference/Events
JPMorgan pharmaceuticals analyst to hold analyst/industry conference call »

Pharmaceuticals Analyst…

09:25
12/11/18
12/11
09:25
12/11/18
09:25
Conference/Events
JPMorgan oilfield service/equip analyst to hold analyst/industry conference call »

Oilfield…

09:25
12/11/18
12/11
09:25
12/11/18
09:25
Conference/Events
UBS Spanish/Italian banking analyst to hold analyst/industry conference call »

Spanish/Italian Banking…

ZION

Zions Bancorp

$44.25

-0.86 (-1.91%)

09:24
12/11/18
12/11
09:24
12/11/18
09:24
Conference/Events
Zions Bancorp management to meet with Sandler O'Neill »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

NKE

Nike

$72.50

-0.86 (-1.17%)

09:24
12/11/18
12/11
09:24
12/11/18
09:24
Recommendations
Nike analyst commentary  »

Nike shares at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Dec

DX

Dynex Capital

$5.95

-0.06 (-1.00%)

09:23
12/11/18
12/11
09:23
12/11/18
09:23
Hot Stocks
Dynex Capital to pay common dividend distributions monthly starting in 2019 »

Dynex Capital announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$365.20

7.355 (2.06%)

09:23
12/11/18
12/11
09:23
12/11/18
09:23
Hot Stocks
Tesla's Musk says tax credit in U.S. going down $3,750 in three weeks »

Tesla CEO Elon Musk says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

SMCI

Super Micro Computer

$0.00

(0.00%)

, AAPL

Apple

$169.61

1.24 (0.74%)

09:23
12/11/18
12/11
09:23
12/11/18
09:23
Periodicals
Super Micro: Probe found no malicious chips in motherboards, Reuters reports »

Super Micro Computer…

SMCI

Super Micro Computer

$0.00

(0.00%)

AAPL

Apple

$169.61

1.24 (0.74%)

AMZN

Amazon.com

$1,640.37

11.18 (0.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 19

    Dec

  • 20

    Dec

PTR

PetroChina

$67.72

-0.84 (-1.23%)

09:22
12/11/18
12/11
09:22
12/11/18
09:22
Downgrade
PetroChina rating change  »

PetroChina downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GTT

GTT Communications

$31.87

0.84 (2.71%)

09:21
12/11/18
12/11
09:21
12/11/18
09:21
Conference/Events
GTT Communications management to meet with Oppenheimer »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

09:20
12/11/18
12/11
09:20
12/11/18
09:20
General news
FOMC could shift to a new rate target as soon as late next year »

FOMC could shift to a new…

09:20
12/11/18
12/11
09:20
12/11/18
09:20
General news
Today's U.S. PPI report revealed slightly stronger than expected gains »

Today's U.S. PPI…

XPER

Xperi

$18.39

5.59 (43.67%)

09:19
12/11/18
12/11
09:19
12/11/18
09:19
Conference/Events
Xperi management to meet with Craig Hallum »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 06

    Jan

ZKIN

ZK International Group

$1.61

-0.02 (-1.23%)

09:19
12/11/18
12/11
09:19
12/11/18
09:19
Hot Stocks
ZK International Group selected by China Railway First Bureau Group »

ZK International Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGRO

Adecogro

09:18
12/11/18
12/11
09:18
12/11/18
09:18
Downgrade
Adecogro rating change  »

Adecogro downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GRTS

Gritstone Oncology

$26.10

-3.28 (-11.16%)

09:18
12/11/18
12/11
09:18
12/11/18
09:18
Recommendations
Gritstone Oncology analyst commentary  »

Gritstone Oncology price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WLDN

Willdan Group

$36.38

-1.07 (-2.86%)

09:18
12/11/18
12/11
09:18
12/11/18
09:18
Conference/Events
Willdan Group management to meet with Roth Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.